Celularity Stock (NASDAQ: CELU) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 99.250K |
Day Range | - - - |
52 Wk Range | 1.590 - 8.900 |
Market Cap | $69.269M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 3.59% |
Days to Cover | 7.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Celularity (NASDAQ: CELU) through any online brokerage.
Other companies in Celularity’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Celularity (NASDAQ: CELU) was reported by Morgan Stanley on Monday, January 30, 2023. The analyst firm set a price target for 1.00 expecting CELU to fall to within 12 months (a possible -68.55% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Celularity (NASDAQ: CELU) is $3.18 last updated April 19, 2024 at 5:00 PM EDT.
There are no upcoming dividends for Celularity.
Celularity’s Q1 earnings are confirmed for Monday, May 20, 2024.
There is no upcoming split for Celularity.
Celularity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.